ReviewClinical parkinsonism & related disorders2026
Stigma and social symptoms in Parkinson's disease: A scoping review.
Review in Clinical parkinsonism & related disorders, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: The incidence of Parkinson's disease (PD) is increasing more rapidly than any other neurodegenerative disorder. Motor and non-motor symptoms, and deficits in cognition and communication, negatively impact people with PD's social functioning and can result in enacted and felt stigma. The aim of this scoping review is to explore the determinants and effects of stigma in PD. Methods: This scoping review followed the Joanna Briggs Institute methodology for scoping reviews. Quantitative and qualitative studies from January 2000 to April 2026 focusing on stigma in PD were considered for inclusion. Databases included Medline via OVID, PsychInfo and Scopus. Results: From 334 screened articles, 25 papers were finally included. Most papers found depression to be a determinant of enacted and felt stigma. Some papers found motor symptoms, younger age, difficulty with activities of daily living, and severe PD to be predictive of stigma. Facial masking, abnormal bodily movement, and speech impairment were linked to felt stigma and to stigmatising attitudes from the general public and clinical practitioners alike. Discussion: Stigmatising views have damaging consequences for people with PD. Negative outcomes of stigma include greater difficulties in the social and emotional spheres, and social avoidance and isolation. More awareness and education for the public, but also healthcare providers, are needed to address negative attitudes and bias towards people with PD. There needs to be more research into interventions to reduce felt stigma, such as psychological training or peer support.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.